Natus Medical Return on Equity

Natus Medical (NTUS) currently reports a ROE of 2.94%. That is below the Healthcare sector average of 21.67%. Use the charts on this page to explore Natus Medical's ROE history and peer comparisons.

Natus Medical's ROE of 2.94% is lower than the Healthcare sector average of 21.67%. That is roughly 86.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Natus Medical's current 2.94% should be judged against Healthcare norms (sector average: 21.67%) and against NTUS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 2.94%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Natus Medical, and consider following NTUS for alerts when major investors trade the stock.

Natus Medical is classified in the Healthcare sector. On ROE, it currently shows 2.94% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NTUS with unrelated industries.